Regent Pacific Group Ltd. Stock Hong Kong S.E.
Equities
0575
KYG7478U1388
Pharmaceuticals
Sales 2021 | 16.84M 132M | Sales 2022 | 35K 274K | Capitalization | 24.28M 190M |
---|---|---|---|---|---|
Net income 2021 | -12M -93.94M | Net income 2022 | -36M -282M | EV / Sales 2021 | 2.91 x |
Net Debt 2021 | 1.68M 13.16M | Net Debt 2022 | 12.29M 96.23M | EV / Sales 2022 | 1,045 x |
P/E ratio 2021 |
-3.73
x | P/E ratio 2022 |
-0.67
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 40.23% |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |